PT - JOURNAL ARTICLE AU - Takashi Morishita AU - Yuki Sakai AU - Hitoshi Iida AU - Saki Yoshimura AU - Atsushi Ishii AU - Shinsuke Fujioka AU - Saori C. Tanaka AU - Tooru Inoue TI - Neuroanatomical Considerations for Optimizing Thalamic Deep Brain Stimulation in Tourette Syndrome AID - 10.1101/2020.09.29.20200501 DP - 2020 Jan 01 TA - medRxiv PG - 2020.09.29.20200501 4099 - http://medrxiv.org/content/early/2020/09/30/2020.09.29.20200501.short 4100 - http://medrxiv.org/content/early/2020/09/30/2020.09.29.20200501.full AB - Background Deep brain stimulation (DBS) of the centromedian (CM) thalamic nucleus has reportedly been used to treat severe Tourette syndrome (TS) with promising outcomes; however, it remains unclear how DBS electrode position and stimulation parameters modulate the specific area and related networks. We aimed to evaluate the relationships between the anatomical location of stimulation fields and clinical responses including therapeutic and side effects.Methods We collected data from eight TS patients treated with DBS. We evaluated the clinical outcomes using Yale Global Tic Severity Scale (YGTSS), Yale-Brown Obsessive Compulsive Scale (Y-BOCS), and Hamilton Depression Rating Scale (HAM-D). The DBS lead location was evaluated in the normalised brain space using a 3-D atlas. The volume of tissue activated (VTA) was determined, and the associated normative connective analyses were performed to link the stimulation field with the therapeutic and side effects.Results The mean follow-up period was 10.9 ± 3.9 months. All clinical scale showed significant significant improvement. While the VTA associated with therapeutic effects covers the CM and ventrolateral nuclei and showed association with motor networks, those associated with paraesthesia and dizziness were associated with stimulation of the ventralis caudalis and red nucleus, respectively. Depressed mood was associated with the spread of stimulation current to the mediodorsal nucleus and showed association with limbic networks.Conclusion Our study addresses the importance of accurate implantation of DBS electrodes for obtaining standardised clinical outcomes and suggests that meticulous programming with careful monitoring of clinical symptoms may improve outcomes.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialUMIN-CTR ID: UMIN000039780 (UMIN = University Medical Information Network; CTR = Clinical Trials Registry.)Funding StatementThis study was partly supported by Japan Society for the Promotion of Science (JSPS) Grant-in-Aid for Scientific Research (C) (Grant number: 18K08956), the Central Research Institute of Fukuoka University (Grant number: 201045), and JSPS KAKENHI Grant (Grant number: JP16H06396).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study was approved by our institutional review board (IRB) named Fukuoka University-Medical Ethics Review Board (IRB approval number: U02-02-001).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData Availability The clinical outcomes of our cohort were registered to the International Tourette Deep Brain Stimulation Database and Registry (https://tourettedeepbrainstimulationregistry.ese.ufhealth.org/). The personal data including the imaging data obtained from the study subjects will not be distributed openly to protect the patients' privacy. We used the population-averaged atlas of the macroscale human structural connectome derived from DWI (http://dsi-studio.labsolver.org/). For imaging analysis, we used free software inclusive of ANTs (http://stnava.github.io/ANTs/) (Avants et al., 2008), Lead-DBS (https://www.lead-dbs.org/) (Horn et al., 2019), PaCER algorithm (Husch et al., 2018), FieldTrip-SimBio (https://www.mrt.uni-jena.de/simbio/index.php/; http://fieldtriptoolbox.org), and DSI studio (http://dsi-studio.labsolver.org). The subject-independent 3D atlases of the thalamic nuclei are also openly available online (http://www.humanmotorthalamus.com/) (Ilinsky et al., 2018). ACAnterior commissureANTsAdvanced Normalisation ToolsCMcentromedianDBSDeep brain stimulationDWIDiffusion-weighted imagingFGATIRfast grey matter acquisition T1 inversion recoveryGPiglobus pallidus internaIPGImplantable pulse generatorMNIMontreal Neurological InstituteMRIMagnetic resonance imagingPCPosterior commissurePWPulse widthRNRed nucleusTSTourette syndromeVTAVolume of tissue activatedYGTSSYale Global Tic Severity Scale